Concepedia

Publication | Closed Access

1192MO Amivantamab monotherapy and in combination with lazertinib in post-osimertinib EGFR-mutant NSCLC: Analysis from the CHRYSALIS study

DOI

31

Citations

0

References

2021

Year

N. B. Leighl, Catherine A. Shu, Anna Minchom, Enriqueta Felip, Sophie Cousin, B.C. Cho, K. Park, J-Y. Han, Michael Boyer, C.K. Lee,
Annals of Oncology

No additional data available for this publication yet. Check back later!